News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
Attitudes towards PrEP uptake and adherence explored in Masaka, Uganda
HIV R4P Virtual: HIV prevalence and incidence among female sex workers participating in a phase IIB HIV vaccine preparedness study in Dar es Salaam,Tanzania
HIV R4P Virtual: Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda
HIV R4P Virtual: Changes in risky sexual behaviour among adult men and women in an HIV vaccine preparedness study in south-western Uganda
HIV R4P Virtual: Recruitment of participants into an HIV vaccine preparedness study: Experiences from Masaka, Uganda
